PRE-EXISTING AND ACQUIRED MORE FREQUENT KD MUTATIONS OF BCR-ABL IN PRIMARY AND SECONDARY RESISTANT IMATINIB-TREATED CML PATIENTS

被引：0
|
作者：
Vrsalovic, M. Marusic [1 ]
Duic, I. [1 ]
Ajdukovic, R. [1 ]
Haris, V. [1 ]
Pejsa, V. [1 ]
Jaksic, O. [1 ]
Kusec, R. [1 ]
机构：
[1] Dubrava Univ Hosp, Zagreb, Croatia
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1316
引用
收藏
页码：533 / 534
页数：2
相关论文
共 50 条
  • [1] The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemia
    Wang, LH
    Knight, K
    Lucas, C
    Clark, RE
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (02): : 235 - 239
  • [2] Spectrum of BCR-ABL Kinase Domain Mutations in North Macedonia in Patients With CML Resistant to Imatinib
    Stojanovska-Jakimovska, Simona
    Cvetanoski, Milche
    Ridova, Nevenka
    Trajkova, Sanja
    Popova-Labachevska, Marija
    Mojsovska, Tara
    Dukovski, Dushko
    Pivkova-Veljanovska, Aleksandra
    Stojanovski, Zlate
    Krstevska-Balkanov, Svetlana
    Pavkovic, Marica
    Chadievski, Lazar
    Panovska-Stavridis, Irina
    Ivanovski, Martin
    Gjorgievska, Emilija
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S375 - S375
  • [3] PREVALENCE OF BCR-ABL IMATINIB RESISTANT MUTATIONS IN PORTUGUESE CHRONIC MYELOID LEUKAEMIA (CML) PATIENTS
    Palmeiro, A.
    Torres, F.
    Lemos, R.
    Teixeira, M.
    Gabriel, H.
    Rendeiro, P.
    Tavares, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 539 - 539
  • [4] BCR-ABL monitoring in imatinib-treated patients with chronic myelogenous leukemia.
    Teitelbaum, A. H.
    Henk, H. J.
    Bollu, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Inadequate BCR-ABL monitoring in imatinib-treated patients with chronic myelogenous leukemia
    Stanek, E.
    Aubert, R. E.
    Sanders, C.
    Frueh, F. W.
    Yao, J.
    Epstein, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] First comprehensive study on pre-existing BCR-ABL KD mutations and subsequent imatinib resistance in CML patients: Value of pre-treatment genetic testing and implication in patient-tailored therapy of leukaemia
    Iqbal, Z.
    Li-Juan, Z.
    Baig, S. M.
    Aziz, Z.
    Shah, I. H.
    Khalid, M.
    Iqbal, M.
    Tanveer, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 40 - 41
  • [7] Dasatinib Efficacy in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Pre-Existing BCR-ABL Mutations
    Mueller, Martin C.
    Cortes, Jorge
    Kim, Dong-Wook
    Druker, Brian J.
    Erben, Philipp
    Pasquini, Ricardo
    Hughes, Timothy P.
    Matloub, Yousif
    Ploughman, Lynn
    Hochhaus, Andreas
    BLOOD, 2008, 112 (11) : 171 - 172
  • [8] Detection of BCR-ABL point mutations in patients with chronic myeloid leukemia (CML) resistant to imatinib.
    Silveira, Rosana A.
    Albuquerque, Dulcineia M.
    Assis, Angela M.
    Ichihara, Edson
    de Souza, Carmino A.
    Costa, Fernando F.
    Delamain, Marcia T.
    Vigorito, Afonso C.
    Lorand-Metze, Irene
    Miranda, Eliana
    Pagnano, Katia B. B.
    BLOOD, 2006, 108 (11) : 289B - 289B
  • [9] The mutation spectrum of CML patients resistant to, imatinib: More heterogeneous than just BCR-ABL kinase domain point mutations?
    Lundan, Tuija
    Gruber, Franz
    Silye, Aleksandra
    Hjorth-Hansen, Henrik
    Mikkola, Ingvild
    Remes, Kari
    Sirnonsson, Bengt
    Gedde-Dahl, Tobias
    Porkka, Kimano
    BLOOD, 2007, 110 (11) : 579A - 579A
  • [10] THERE ARE NOT ONLY POINT MUTATIONS BUT ALSO SPLICING DEFECTS IN BCR-ABL GENE IN CML PATIENTS TREATED BY IMATINIB
    Misyurin, A. V.
    Suchkova, M. V.
    Krutov, A. A.
    Aksenova, E. V.
    Tikhonova, V. V.
    Turkina, A. G.
    Khoroshko, N. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 225 - 225
12345